Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using topiramate in patients with epilepsy: practical aspects

J W Sander1

  • 1Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, United Kingdom.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|August 26, 1998
PubMed
Summary

Practical clinical experience with topiramate (TPM), a new antiepileptic drug, has led to adjusted dosing and titration strategies. These changes aim to improve patient tolerability and optimize the use of TPM in epilepsy treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health.

Neuroscience·2025
Same author

High prevalence of epilepsy in Southern and Northern Rwanda: Myth or reality?

Tropical medicine & international health : TM & IH·2024
Same author

Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy".

Journal of the neurological sciences·2021
Same author

The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers.

Epilepsy & behavior reports·2021
Same author

Comparing two classification schemes for seizures and epilepsy in rural China.

European journal of neurology·2018
Same author

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

European journal of neurology·2018

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Clinical trials establish initial efficacy and safety of new antiepileptic drugs (AEDs).
  • Real-world clinical practice refines the application and positioning of AEDs within treatment options.

Purpose of the Study:

  • To provide practical guidance on the use of topiramate (TPM) based on post-marketing clinical experience.
  • To outline strategies for optimizing TPM tolerability and effectiveness.

Main Methods:

  • Review of clinical practice experience with topiramate (TPM) in the United Kingdom since 1995.
  • Analysis of adjustments in starting doses, titration rates, and side effect management.

Main Results:

  • Modified starting doses and titration rates for TPM have improved patient tolerability.

Related Experiment Videos

  • Practical tips for managing early side effects, withdrawing concomitant AEDs, and discontinuing TPM have been developed.

    • Conclusions:

    • Clinical practice experience has refined the optimal use of topiramate (TPM).
    • Adjusted dosing, titration, and patient counseling are crucial for maximizing TPM's therapeutic benefit in epilepsy management.